Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DX25F6SAS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $10,399
Award facts
- Contract value 100% obligated
- $10,398.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections with a ceiling value of $10,398.61. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX and valued at $999,999,999.00 through December 2026). The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania, with a completion deadline of July 23, 2025. Zepbound is a GLP-1 receptor agonist used for weight management in adults, and this award reflects the federal government's procurement of pharmaceutical products to support military healthcare operations.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor on this award. The delivery order exemplifies the company's extensive federal contracting portfolio with the Defense Logistics Agency, through which it supplies a comprehensive range of pharmaceuticals and medical supplies to support military, veteran, and Coast Guard healthcare systems. This non-set-aside competitive award demonstrates AmerisourceBergen's ongoing capability to fulfill federal medical procurement requirements, consistent with its role as a primary vendor under the DLA's pharmaceutical support framework.
Quick answers
Who was awarded contract SPE2DX25F6SAS?
SPE2DX25F6SAS was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on July 22, 2025.
How much is contract SPE2DX25F6SAS worth?
The government has obligated $10,399 on SPE2DX25F6SAS.
Is contract SPE2DX25F6SAS an order under another contract?
Yes. SPE2DX25F6SAS is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6SAS competed?
The extent of competition for SPE2DX25F6SAS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award